标题
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
作者
关键词
Weight gain, Meta-analysis, Body weight, Weight loss, Antipsychotics, Schizophrenia, Drug metabolism, Randomized controlled trials
出版物
PLoS One
Volume 9, Issue 4, Pages e94112
出版商
Public Library of Science (PLoS)
发表日期
2014-04-25
DOI
10.1371/journal.pone.0094112
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A Comparison of Ziprasidone and Risperidone in the Long-Term Treatment of Schizophrenia: A 44-Week, Double-Blind, Continuation Study
- (2017) Donald E Addington et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Extended Release Quetiapine Fumarate Monotherapy for Major Depressive Disorder: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2016) Richard Weisler et al. CNS SPECTRUMS
- Metabolic syndrome in people with schizophrenia: a review
- (2015) MARC DE HERT et al. World Psychiatry
- Switching Antipsychotic Medications to Reduce Adverse Event Burden in Schizophrenia: Establishing Evidence-Based Practice
- (2013) John W. Newcomer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Depression and Risk of Mortality in People with Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2013) Fleur E. P. van Dooren et al. PLoS One
- Weight Considerations in Psychotropic Drug Prescribing and Switching
- (2013) Mehrul Hasnain et al. POSTGRADUATE MEDICINE
- A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications
- (2012) Michael Beary et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
- (2011) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- Metabolic Risk with Second-Generation Antipsychotic Treatment: A Double-Blind Randomized 8-Week Trial of Risperidone and Olanzapine
- (2011) Deanna L. Kelly et al. Annals of Clinical Psychiatry
- Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia
- (2011) Angela L Hill et al. BMC Psychiatry
- Dose Pattern and Effectiveness of Paliperidone Extended-Release Tablets in Patients With Schizophrenia
- (2011) Jung-Sun Lee et al. CLINICAL NEUROPHARMACOLOGY
- Impact of olanzapine or risperidone treatment on insulin sensitivity in schizophrenia or schizoaffective disorder
- (2011) T. A. Hardy et al. DIABETES OBESITY & METABOLISM
- A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment
- (2011) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder
- (2011) Mary C. Zanarini et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Review and Bayesian Meta-Analysis of Clinical Efficacy and Adverse Effects of 4 Atypical Neuroleptic Drugs Compared With Haloperidol and Placebo
- (2011) Marianne Klemp et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Randomized, Double-Blind, Parallel-Group, Fixed-Dose, Clinical Trial of Quetiapine at 600 Versus 1200 mg/d for Patients With Treatment-Resistant Schizophrenia or Schizoaffective Disorder
- (2011) Jean-Pierre Lindenmayer et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Open-Label Trial of Aripiprazole in the Treatment of Trichotillomania
- (2011) Matthew P. White et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Switching from Quetiapine to Ziprasidone
- (2011) Onur N. Karayal et al. Journal of Psychiatric Practice
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Weight Changes and their Associations with Demographic and Clinical Characteristics in Risperidone Maintenance Treatment for Schizophrenia
- (2011) Y.-T. Xiang et al. PHARMACOPSYCHIATRY
- A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test
- (2011) Chun-Hsin Chen et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes
- (2011) Serge Sevy et al. PSYCHIATRY RESEARCH
- Prediction of long-term metabolic effects of olanzapine and risperidone treatment from baseline body mass index in schizophrenia and bipolar disorder
- (2011) William Victor Bobo et al. PSYCHIATRY RESEARCH
- Effectiveness of maintenance treatments with atypical and typical antipsychotics in stable schizophrenia with early stage: 1-year naturalistic study
- (2011) Xiaofeng Guo et al. PSYCHOPHARMACOLOGY
- Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis
- (2011) Alex J. Mitchell et al. SCHIZOPHRENIA BULLETIN
- Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder
- (2011) Steven G. Potkin et al. SCHIZOPHRENIA RESEARCH
- Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
- (2011) M R Louza et al. Neuropsychiatric Disease and Treatment
- Amisulpride Versus Olanzapine in the Treatment of Schizophrenia in Indian Patients: Randomized Controlled Trial
- (2010) Subhrojyoti Bhowmick et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Risperidone Long-Acting Injectable Monotherapy in the Maintenance Treatment of Bipolar I Disorder
- (2010) Jorge A. Quiroz et al. BIOLOGICAL PSYCHIATRY
- Effectiveness of Switching From Aripiprazole to Ziprasidone in Patients With Schizophrenia
- (2010) Sung-Wan Kim et al. CLINICAL NEUROPHARMACOLOGY
- Efficacy and Tolerability of Blonanserin in the Patients With Schizophrenia
- (2010) Jaewon Yang et al. CLINICAL NEUROPHARMACOLOGY
- Safety and efficacy of long-acting injectable risperidone in daily practice: an open-label, noninterventional, prospective study in schizophrenia and related disorders
- (2010) Eduard Parellada et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone
- (2010) Carla M. Canuso et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study
- (2010) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Asenapine in the treatment of acute mania in bipolar I disorder: A randomized, double-blind, placebo-controlled trial
- (2010) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study☆
- (2010) Brian Bortnick et al. JOURNAL OF AFFECTIVE DISORDERS
- Metabolic Syndrome in Patients Enrolled in a Clinical Trial of Aripiprazole in the Maintenance Treatment of Bipolar I Disorder
- (2010) David E. Kemp et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Double-Blind, Randomized Study Comparing the Efficacy and Safety of Sertindole and Risperidone in Patients With Treatment-Resistant Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania
- (2010) Michael Van Ameringen et al. JOURNAL OF CLINICAL PSYCHIATRY
- A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia
- (2010) S Gopal et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
- (2010) J. Schoemaker et al. PHARMACOPSYCHIATRY
- The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine
- (2010) Chih-Chiang Chiu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia
- (2010) Gahan Pandina et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia
- (2010) Herbert Y. Meltzer et al. PSYCHIATRY RESEARCH
- Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study
- (2010) Istvan Bitter et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting
- (2010) Ming-Hong Hsieh et al. Annals of General Psychiatry
- Obesity Among Those with Mental Disorders
- (2009) David B. Allison et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia
- (2009) John M. Kane et al. AMERICAN JOURNAL OF PSYCHIATRY
- A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states
- (2009) Roger S McIntyre et al. BIPOLAR DISORDERS
- Effect of overweight on gastrointestinal microbiology and immunology: correlation with blood biomarkers
- (2009) Kirsti Tiihonen et al. BRITISH JOURNAL OF NUTRITION
- Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study
- (2009) Allan H. Young et al. BRITISH JOURNAL OF PSYCHIATRY
- Efficacy and Tolerability of Aripiprazole in First-Episode Drug-Naive Patients With Schizophrenia
- (2009) Hitoshi Takahashi et al. CLINICAL NEUROPHARMACOLOGY
- Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders
- (2009) Mario Álvarez-Jiménez et al. CNS DRUGS
- Antipsychotic switching: results from a one-year prospective, observational study of patients with schizophrenia
- (2009) Jamie Karagianis et al. CURRENT MEDICAL RESEARCH AND OPINION
- Obesity, serious mental illness and antipsychotic drugs
- (2009) Richard I. G. Holt et al. DIABETES OBESITY & METABOLISM
- Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk—a review of the literature
- (2009) R Huxley et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Waist circumference and waist/hip ratio in relation to all-cause mortality, cancer and sleep apnea
- (2009) J C Seidell EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study
- (2009) Chi-Un Pae et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Belgian Schizophrenia Outcome Survey – Results of a 2-year naturalistic study in patients stabilised on monotherapy with olanzapine, risperidone or haloperidol
- (2009) J. Peuskens et al. EUROPEAN PSYCHIATRY
- How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins
- (2009) F.C.J. Starrenburg et al. EUROPEAN PSYCHIATRY
- Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia
- (2009) Sung-Wan Kim et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia
- (2009) Kyoung-Uk Lee et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder
- (2009) Alessandro Rossi et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: results of an 8-week open label trial
- (2009) William V. Bobo et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients
- (2009) Rao N. Malempati et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia
- (2009) Hans-Jürgen Möller et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Weight gain during olanzapine treatment for psychotic depression: effects of dose and age
- (2009) Eric Smith et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study
- (2009) Koksal Alptekin et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
- (2009) Trisha Suppes et al. JOURNAL OF AFFECTIVE DISORDERS
- The Moderating Impact of Ethnicity on Metabolic Outcomes During Treatment With Olanzapine and Aripiprazole in Patients With Schizophrenia
- (2009) Jonathan M. Meyer et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized, Double-Blind, Placebo-Controlled Trial of Long-Acting Risperidone in Cocaine-Dependent Men
- (2009) Tsafrir Loebl et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Multicenter, Randomized, Double-Blind Study of the Effects of Aripiprazole in Overweight Subjects With Schizophrenia or Schizoaffective Disorder Switched From Olanzapine
- (2009) John W. Newcomer et al. JOURNAL OF CLINICAL PSYCHIATRY
- An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia
- (2009) John Lauriello et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Tolerability of Oral Paliperidone Extended-Release Tablets in the Treatment of Acute Schizophrenia
- (2009) Herbert Y. Meltzer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Predicted Risk of Diabetes and Coronary Heart Disease in Patients With Schizophrenia
- (2009) Lawrence Blonde et al. JOURNAL OF CLINICAL PSYCHIATRY
- Aripiprazole Therapy in 20 Older Adults With Bipolar Disorder
- (2009) Martha Sajatovic et al. JOURNAL OF CLINICAL PSYCHIATRY
- Olanzapine in the Treatment of Pathological Gambling
- (2009) Susan L. McElroy et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comorbid Somatic Illnesses in Patients With Severe Mental Disorders
- (2009) W. Wolfgang Fleishhacker et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia
- (2009) Herbert Y. Meltzer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Managing Weight Gain and Metabolic Issues in Patients Treated With Atypical Antipsychotics
- (2009) David C. Henderson JOURNAL OF CLINICAL PSYCHIATRY
- A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia
- (2009) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effects of Olanzapine and Risperidone on Glucose Metabolism and Insulin Sensitivity in Chronic Schizophrenic Patients With Long-Term Antipsychotic Treatment
- (2009) Robert C. Smith et al. JOURNAL OF CLINICAL PSYCHIATRY
- Obesity in Patients With Severe Mental Illness
- (2009) Susan L. McElroy JOURNAL OF CLINICAL PSYCHIATRY
- A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone
- (2009) John W. Newcomer et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comparing the Safety and Efficacy of Atypical Antipsychotics in Psychiatric Patients With Comorbid Medical Illnesses
- (2009) John W. Newcomer JOURNAL OF CLINICAL PSYCHIATRY
- Lurasidone in the Treatment of Acute Schizophrenia
- (2009) Mitsutaka Nakamura et al. JOURNAL OF CLINICAL PSYCHIATRY
- Aripiprazole Monotherapy in Nonpsychotic Bipolar I Depression
- (2009) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Comparison of the Effects of Olanzapine and Risperidone Versus Placebo on Ghrelin Plasma Levels
- (2009) James L. Roerig et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Long-Acting Injectable Risperidone in the Treatment of Subjects With Recent-Onset Psychosis
- (2009) Robin Emsley et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Standard and Higher Dose of Olanzapine in Patients With Schizophrenia or Schizoaffective Disorder
- (2009) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia
- (2009) C. Bushe et al. JOURNAL OF PSYCHOPHARMACOLOGY
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
- (2009) Jari Tiihonen et al. LANCET
- Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications
- (2009) S. Gentile Obesity Reviews
- Switching to Aripiprazole in Outpatients with Schizophrenia Experiencing Insufficient Efficacy and/or Safety/Tolerability Issues with Risperidone: A Randomized, Multicentre, Open-label Study
- (2009) V. Ryckmans et al. PHARMACOPSYCHIATRY
- Weight gain in antipsychotic-naive patients: a review and meta-analysis
- (2009) I. Tarricone et al. PSYCHOLOGICAL MEDICINE
- Second-generation antipsychotics for schizophrenia: can we resolve the conflict?
- (2009) S. Leucht et al. PSYCHOLOGICAL MEDICINE
- Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol
- (2009) Menahem Krakowski et al. SCHIZOPHRENIA RESEARCH
- A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study
- (2009) J. Karagianis et al. SCHIZOPHRENIA RESEARCH
- Influence of antipsychotics on mortality in schizophrenia: Systematic review
- (2009) Stefan Weinmann et al. SCHIZOPHRENIA RESEARCH
- Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: The MOZART study
- (2009) Emilio Sacchetti et al. SCHIZOPHRENIA RESEARCH
- Effectiveness of second-generation antipsychotics with acute-phase schizophrenia
- (2009) Kotaro Hatta et al. SCHIZOPHRENIA RESEARCH
- Weight effects associated with antipsychotics: A comprehensive database analysis
- (2009) Bruce Parsons et al. SCHIZOPHRENIA RESEARCH
- The cumulative needs for care monitor: a unique monitoring system in the south of the Netherlands
- (2009) Marjan Drukker et al. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
- Olanzapine orally disintegrating tablets (Zyprexa ZydisR) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: An open-label prospective study
- (2009) Hikaru Hori et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: Results from a six-month prospective, multinational, observational study
- (2009) Tamás Treuer et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Diabetes and schizophrenia – effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia
- (2008) S. Saddichha et al. ACTA PSYCHIATRICA SCANDINAVICA
- A Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole for the Treatment of Psychosis in Nursing Home Patients with Alzheimer Disease
- (2008) Joel E. Streim et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- A Double-Blind, Randomized Comparative Study of Aripiprazole and Olanzapine in Patients with Schizophrenia
- (2008) W. Wolfgang Fleischhacker et al. BIOLOGICAL PSYCHIATRY
- Quetiapine for the treatment of bipolar mania in older adults
- (2008) Martha Sajatovic et al. BIPOLAR DISORDERS
- Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder
- (2008) Ruud van Winkel et al. BIPOLAR DISORDERS
- Effectiveness of second generation antipsychotics: A systematic review of randomized trials
- (2008) Erik Johnsen et al. BMC Psychiatry
- Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study
- (2008) S. Charles Schulz et al. BRITISH JOURNAL OF PSYCHIATRY
- Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trials
- (2008) Mario Álvarez-Jiménez et al. BRITISH JOURNAL OF PSYCHIATRY
- Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophrenia
- (2008) Douglas E. Faries et al. CURRENT MEDICAL RESEARCH AND OPINION
- Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial
- (2008) Bharat Chawla et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone
- (2008) Carla M. Canuso et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies
- (2008) Robin Emsley et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study
- (2008) D. J. Muzina et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety
- (2008) David V. Sheehan et al. JOURNAL OF AFFECTIVE DISORDERS
- Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study
- (2008) P.E. Keck et al. JOURNAL OF AFFECTIVE DISORDERS
- Olanzapine Versus Aripiprazole for the Treatment of Agitation in Acutely Ill Patients With Schizophrenia
- (2008) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Long-Term Efficacy and Safety of Iloperidone
- (2008) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Safety Profile of Iloperidone
- (2008) Peter J. Weiden et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia
- (2008) Marilyn Ader et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study
- (2008) Josep Maria Haro et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Building a better antipsychotic: Receptor targets for the treatment of multiple symptom dimensions of schizophrenia
- (2008) Dennis H. Kim et al. Neurotherapeutics
- A Double-blind Placebo-controlled Discontinuation Study of Zuclopenthixol for the Treatment of Aggressive Disruptive Behaviours in Adults with Mental Retardation – Secondary Parameter Analyses
- (2008) F. Häßler et al. PHARMACOPSYCHIATRY
- Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever
- (2008) Michael Kluge et al. PSYCHONEUROENDOCRINOLOGY
- Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review
- (2008) Marc De Hert et al. SCHIZOPHRENIA RESEARCH
- Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects
- (2008) Karen A. Graham et al. SCHIZOPHRENIA RESEARCH
- Results of phase 3 of the CATIE schizophrenia trial
- (2008) T. Scott Stroup et al. SCHIZOPHRENIA RESEARCH
- A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: The QUERISOLA trial
- (2007) Emilio Sacchetti et al. SCHIZOPHRENIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search